Target intelligence / Profile preview

T cell receptor alpha variable 31 (TRAV31)

Target
TRAV31
Molecular classification
Immunoglobulin superfamily segment (variable region), Pseudogene (does not encode a functional protein)
01

Overview

T cell receptor alpha variable 31 (TRAV31) is a gene segment within the T-cell receptor alpha locus responsible for contributing to TCR diversity via V(D)J recombination in T cells. In humans, TRAV31 is classified as a pseudogene, meaning it does not encode a functional variable region protein for the T-cell receptor. T-cell receptors as a whole are membrane-bound heterodimers involved in antigen recognition, immune signaling, and immune response, but specific pseudogene variable segments like TRAV31 do not have direct functional or therapeutic relevance[1][3][4].

Other names
TCRAV31S1TRAV31
02

Mechanism of action

None applicable

03

Biological functions

None (no direct biological function, as it does not encode protein)
04

Disease associations

None established (no role documented in disease due to its pseudogene status)
05

Safety considerations

None specific; pseudogenes have no known safety implications

Beyond the preview

Go deeper on T cell receptor alpha variable 31 (TRAV31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 31 (TRAV31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call